| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamine-fructose-6-phosphate transaminase (isomerizing) activity | 7.52e-08 | 2 | 6 | 2 | GO:0004360 | |
| GeneOntologyMolecularFunction | L-glutamine aminotransferase activity | 2.26e-07 | 3 | 6 | 2 | GO:0070548 | |
| GeneOntologyMolecularFunction | transaminase activity | 2.44e-05 | 26 | 6 | 2 | GO:0008483 | |
| GeneOntologyMolecularFunction | transferase activity, transferring nitrogenous groups | 2.83e-05 | 28 | 6 | 2 | GO:0016769 | |
| GeneOntologyBiologicalProcess | UDP-N-acetylglucosamine biosynthetic process | 2.54e-06 | 9 | 6 | 2 | GO:0006048 | |
| GeneOntologyBiologicalProcess | amino sugar biosynthetic process | 3.87e-06 | 11 | 6 | 2 | GO:0046349 | |
| GeneOntologyBiologicalProcess | UDP-N-acetylglucosamine metabolic process | 6.41e-06 | 14 | 6 | 2 | GO:0006047 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 8.45e-06 | 16 | 6 | 2 | GO:0006002 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar biosynthetic process | 1.78e-05 | 23 | 6 | 2 | GO:0009226 | |
| GeneOntologyBiologicalProcess | glutamine metabolic process | 3.06e-05 | 30 | 6 | 2 | GO:0006541 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar metabolic process | 6.64e-05 | 44 | 6 | 2 | GO:0009225 | |
| GeneOntologyBiologicalProcess | amino sugar metabolic process | 7.58e-05 | 47 | 6 | 2 | GO:0006040 | |
| GeneOntologyBiologicalProcess | protein N-linked glycosylation | 1.99e-04 | 76 | 6 | 2 | GO:0006487 | |
| GeneOntologyBiologicalProcess | glutamine family amino acid metabolic process | 2.21e-04 | 80 | 6 | 2 | GO:0009064 | |
| GeneOntologyBiologicalProcess | energy reserve metabolic process | 4.48e-04 | 114 | 6 | 2 | GO:0006112 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 1.17e-03 | 185 | 6 | 2 | GO:0170039 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-binding transcription factor activity | 1.21e-03 | 188 | 6 | 2 | GO:0043433 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 1.48e-03 | 208 | 6 | 2 | GO:0170033 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | 2.14e-03 | 251 | 6 | 2 | GO:1901605 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 2.16e-03 | 252 | 6 | 2 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 2.16e-03 | 252 | 6 | 2 | GO:0006486 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 2.47e-03 | 270 | 6 | 2 | GO:0007160 | |
| GeneOntologyBiologicalProcess | glycosylation | 2.47e-03 | 270 | 6 | 2 | GO:0070085 | |
| GeneOntologyBiologicalProcess | amino acid metabolic process | 3.71e-03 | 332 | 6 | 2 | GO:0006520 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 4.28e-03 | 357 | 6 | 2 | GO:0009101 | |
| GeneOntologyBiologicalProcess | energy derivation by oxidation of organic compounds | 4.96e-03 | 385 | 6 | 2 | GO:0015980 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 5.61e-03 | 410 | 6 | 2 | GO:0031589 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 6.15e-03 | 430 | 6 | 2 | GO:0009100 | |
| GeneOntologyBiologicalProcess | regulation of DNA-binding transcription factor activity | 6.69e-03 | 449 | 6 | 2 | GO:0051090 | |
| GeneOntologyCellularComponent | chromosomal region | 5.75e-03 | 421 | 6 | 2 | GO:0098687 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 8.64e-03 | 519 | 6 | 2 | GO:0009897 | |
| Domain | GlmS_trans | 8.60e-08 | 2 | 6 | 2 | IPR005855 | |
| Domain | SIS | 8.60e-08 | 2 | 6 | 2 | PF01380 | |
| Domain | SIS | 2.58e-07 | 3 | 6 | 2 | PS51464 | |
| Domain | SIS | 2.58e-07 | 3 | 6 | 2 | IPR001347 | |
| Domain | GATASE_TYPE_2 | 8.60e-07 | 5 | 6 | 2 | PS51278 | |
| Domain | GATase_2_dom | 8.60e-07 | 5 | 6 | 2 | IPR017932 | |
| Domain | - | 2.37e-05 | 24 | 6 | 2 | 3.60.20.10 | |
| Domain | Ntn_hydrolases_N | 4.52e-05 | 33 | 6 | 2 | IPR029055 | |
| Domain | VWF_A | 4.11e-04 | 99 | 6 | 2 | IPR002035 | |
| Pathway | REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE | 4.22e-06 | 8 | 6 | 2 | M27375 | |
| Pathway | REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE | 4.22e-06 | 8 | 6 | 2 | MM15121 | |
| Pathway | KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM | 7.45e-05 | 32 | 6 | 2 | M17758 | |
| Pathway | KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM | 1.42e-04 | 44 | 6 | 2 | M8104 | |
| Pathway | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | 3.01e-04 | 64 | 6 | 2 | M892 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | 4.36e-04 | 77 | 6 | 2 | MM15118 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | 4.58e-04 | 79 | 6 | 2 | M897 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 6.11e-03 | 293 | 6 | 2 | MM15120 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 6.69e-03 | 307 | 6 | 2 | M894 | |
| Pubmed | 2.48e-08 | 2 | 6 | 2 | 9060444 | ||
| Pubmed | Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2. | 2.48e-08 | 2 | 6 | 2 | 34735873 | |
| Pubmed | GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway. | 7.44e-08 | 3 | 6 | 2 | 35229715 | |
| Pubmed | 1.49e-07 | 4 | 6 | 2 | 17542649 | ||
| Pubmed | 2.48e-07 | 5 | 6 | 2 | 26887390 | ||
| Pubmed | 1.93e-06 | 13 | 6 | 2 | 10198162 | ||
| Pubmed | 1.30e-05 | 304 | 6 | 3 | 32235678 | ||
| Pubmed | 4.67e-05 | 62 | 6 | 2 | 19710015 | ||
| Pubmed | 9.87e-05 | 90 | 6 | 2 | 30228991 | ||
| Pubmed | 1.26e-04 | 653 | 6 | 3 | 33742100 | ||
| Pubmed | 1.60e-04 | 708 | 6 | 3 | 39231216 | ||
| Interaction | KCNA3 interactions | 4.85e-05 | 871 | 6 | 4 | int:KCNA3 | |
| Interaction | AHSA1 interactions | 5.95e-05 | 294 | 6 | 3 | int:AHSA1 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 3.06e-05 | 38 | 6 | 2 | M10487 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 4.11e-05 | 44 | 6 | 2 | MM805 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 6.24e-04 | 171 | 6 | 2 | M39234 | |
| Coexpression | GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN | 6.68e-04 | 177 | 6 | 2 | M8794 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 7.61e-04 | 189 | 6 | 2 | M8275 | |
| Coexpression | GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN | 7.93e-04 | 193 | 6 | 2 | M8725 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN | 8.35e-04 | 198 | 6 | 2 | M8723 | |
| Coexpression | GSE11924_TH1_VS_TH2_CD4_TCELL_DN | 8.43e-04 | 199 | 6 | 2 | M3160 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN | 8.43e-04 | 199 | 6 | 2 | M8721 | |
| Coexpression | GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP | 8.52e-04 | 200 | 6 | 2 | M9254 | |
| Coexpression | GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN | 8.52e-04 | 200 | 6 | 2 | M3491 | |
| Coexpression | GSE3982_MAC_VS_BASOPHIL_UP | 8.52e-04 | 200 | 6 | 2 | M5496 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 9.21e-04 | 208 | 6 | 2 | M39233 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-05 | 79 | 6 | 2 | 4c9c3051cb8a9c39c6df20e3fe37242db4b44280 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-05 | 79 | 6 | 2 | eddad041c0bc6952d9c68a36bdd78f6d661f0e58 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.83e-05 | 110 | 6 | 2 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.89e-04 | 161 | 6 | 2 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Th1|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-04 | 172 | 6 | 2 | c0c9a3f5b5fb942b049bc159fd9f21b5b706edd2 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 2.26e-04 | 176 | 6 | 2 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 183 | 6 | 2 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 183 | 6 | 2 | f142b320023eef00b48d4820c46214c9794d37e7 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 183 | 6 | 2 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 185 | 6 | 2 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 2.63e-04 | 190 | 6 | 2 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 2.69e-04 | 192 | 6 | 2 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| Drug | Sch 37137 | 5.79e-08 | 2 | 6 | 2 | CID000197244 | |
| Drug | Lys-Nva-FMDP | 5.79e-08 | 2 | 6 | 2 | CID006475796 | |
| Drug | FMDP-Val | 5.79e-08 | 2 | 6 | 2 | CID006475745 | |
| Drug | Avl-FMDP | 1.74e-07 | 3 | 6 | 2 | CID006473933 | |
| Drug | 5 PA | 1.74e-07 | 3 | 6 | 2 | CID000004324 | |
| Drug | 3-amino-3-deoxy-D-glucose | 1.74e-07 | 3 | 6 | 2 | CID000164683 | |
| Drug | kanosamine-6-phosphate | 1.74e-07 | 3 | 6 | 2 | CID000443710 | |
| Drug | 2-amino-2-deoxy-D-glucitol 6-phosphate | 3.47e-07 | 4 | 6 | 2 | CID000001554 | |
| Drug | AC1O5Y0I | 3.47e-07 | 4 | 6 | 2 | CID006442853 | |
| Drug | fenticonazole | 5.79e-07 | 5 | 6 | 2 | CID000051754 | |
| Drug | KW-5805 | 5.79e-07 | 5 | 6 | 2 | CID000175662 | |
| Drug | NSC-7365 | 8.68e-07 | 6 | 6 | 2 | CID000000164 | |
| Drug | AC1L19VH | 8.68e-07 | 6 | 6 | 2 | CID000000721 | |
| Drug | D-glucosamine-6P | 1.62e-06 | 8 | 6 | 2 | CID000121988 | |
| Drug | N-carbethoxyhistidine | 1.62e-06 | 8 | 6 | 2 | CID000152942 | |
| Drug | FcDP | 2.08e-06 | 9 | 6 | 2 | CID006439892 | |
| Drug | GU-5 | 2.60e-06 | 10 | 6 | 2 | CID000448682 | |
| Drug | AC1Q6RZ4 | 3.04e-06 | 123 | 6 | 3 | CID000000719 | |
| Drug | AC1O5Q4M | 3.18e-06 | 11 | 6 | 2 | CID006438678 | |
| Drug | AC1L1AVN | 3.18e-06 | 11 | 6 | 2 | CID000001168 | |
| Drug | bacilysin | 6.07e-06 | 15 | 6 | 2 | CID000160175 | |
| Drug | 2-methyleneglutarate | 6.93e-06 | 16 | 6 | 2 | CID000095155 | |
| Drug | Corlan | 6.93e-06 | 16 | 6 | 2 | CID000003643 | |
| Drug | glucosaminitol | 6.93e-06 | 16 | 6 | 2 | CID000189022 | |
| Drug | allulose 6-phosphate | 6.96e-06 | 162 | 6 | 3 | CID000000603 | |
| Drug | d-arabino-3-hexulose 6-phosphate | 7.86e-06 | 17 | 6 | 2 | CID000193886 | |
| Drug | albizziin | 8.84e-06 | 18 | 6 | 2 | CID000092891 | |
| Drug | histidinol phosphate | 9.88e-06 | 19 | 6 | 2 | CID000000845 | |
| Drug | anticapsin | 9.88e-06 | 19 | 6 | 2 | CID000072647 | |
| Drug | NK 631 | 9.88e-06 | 19 | 6 | 2 | CID000004741 | |
| Drug | glucosamine-1-P | 1.10e-05 | 20 | 6 | 2 | CID000000740 | |
| Drug | AC1L19VE | 1.10e-05 | 20 | 6 | 2 | CID000000720 | |
| Drug | fructosyl-lysine | 1.21e-05 | 21 | 6 | 2 | CID000123708 | |
| Drug | 2-deoxy-D-glucose 6-phosphate | 1.21e-05 | 21 | 6 | 2 | CID000440992 | |
| Drug | AC1LAED8 | 1.21e-05 | 21 | 6 | 2 | CID000486506 | |
| Drug | AC1NUW81 | 1.33e-05 | 22 | 6 | 2 | CID005462220 | |
| Drug | 3alpha, 7beta-dihydroxy-5beta-cholan-24-oic acid | 1.43e-05 | 206 | 6 | 3 | CID000005645 | |
| Drug | Aadp | 1.46e-05 | 23 | 6 | 2 | CID000163551 | |
| Drug | kanosamine | 1.59e-05 | 24 | 6 | 2 | CID000443709 | |
| Drug | Glcnac6P | 1.73e-05 | 25 | 6 | 2 | CID000150941 | |
| Drug | p-iodophenol | 2.34e-05 | 29 | 6 | 2 | CID000010894 | |
| Drug | AC1L1JAL | 2.34e-05 | 29 | 6 | 2 | CID000004954 | |
| Drug | ketose | 2.68e-05 | 31 | 6 | 2 | CID000439494 | |
| Drug | AC1NBT2J | 2.86e-05 | 32 | 6 | 2 | CID003958805 | |
| Drug | aldohexose 6-phosphate | 3.04e-05 | 33 | 6 | 2 | CID000085186 | |
| Drug | CID11980859 | 3.23e-05 | 34 | 6 | 2 | CID011980859 | |
| Drug | GAMs | 4.05e-05 | 38 | 6 | 2 | CID000002935 | |
| Drug | Vitamin K1-d7 | 4.49e-05 | 40 | 6 | 2 | CID000004812 | |
| Drug | L-glutamic acid gamma-monohydroxamate | 4.72e-05 | 41 | 6 | 2 | CID000003484 | |
| Drug | ManNAc-6-P | 4.96e-05 | 42 | 6 | 2 | CID000000898 | |
| Drug | 4,4'-dithiodipyridine | 5.70e-05 | 45 | 6 | 2 | CID000075846 | |
| Drug | AC1Q6RZL | 6.22e-05 | 47 | 6 | 2 | CID000001144 | |
| Drug | AC1NDTNH | 6.55e-05 | 343 | 6 | 3 | CID004631409 | |
| Drug | AC1L96SZ | 7.05e-05 | 50 | 6 | 2 | CID000439166 | |
| Drug | dimethylmercury | 7.63e-05 | 52 | 6 | 2 | CID000011645 | |
| Drug | AC1Q6RYL | 7.93e-05 | 53 | 6 | 2 | CID000000606 | |
| Drug | glutamic gamma-semialdehyde | 7.93e-05 | 53 | 6 | 2 | CID000000844 | |
| Drug | adenosylcobalamin | 7.93e-05 | 53 | 6 | 2 | CID000424379 | |
| Drug | pyrroline-5-carboxylate | 8.23e-05 | 54 | 6 | 2 | CID000001196 | |
| Drug | pyridoxamine 5'-phosphate | 8.86e-05 | 56 | 6 | 2 | CID000001053 | |
| Drug | N V A | 9.50e-05 | 58 | 6 | 2 | CID000000824 | |
| Drug | AC1Q6RZ6 | 1.02e-04 | 60 | 6 | 2 | CID000000609 | |
| Drug | CH3Hg | 1.02e-04 | 60 | 6 | 2 | CID000007905 | |
| Drug | diaminopropionic acid | 1.05e-04 | 61 | 6 | 2 | CID000000364 | |
| Drug | o-diazoacetyl-L-serine | 1.09e-04 | 62 | 6 | 2 | CID000000830 | |
| Drug | longum | 1.12e-04 | 63 | 6 | 2 | CID000009047 | |
| Drug | AC1OCA7P | 1.19e-04 | 65 | 6 | 2 | CID006914565 | |
| Drug | pyruvic acid | 1.23e-04 | 424 | 6 | 3 | CID000001060 | |
| Drug | AC1O3LUB | 1.23e-04 | 66 | 6 | 2 | CID006331868 | |
| Drug | 13-HPODE | 1.55e-04 | 74 | 6 | 2 | CID000001426 | |
| Drug | 1-aminoindan | 1.55e-04 | 74 | 6 | 2 | CID000123445 | |
| Drug | AC1L9A0M | 1.55e-04 | 74 | 6 | 2 | CID000440822 | |
| Drug | ribulose | 1.55e-04 | 74 | 6 | 2 | CID000000619 | |
| Drug | NP-L3VS | 1.59e-04 | 75 | 6 | 2 | CID005288713 | |
| Drug | N-acetylhexosamine | 1.69e-04 | 472 | 6 | 3 | CID000000899 | |
| Drug | L-Ft | 1.72e-04 | 78 | 6 | 2 | CID000451514 | |
| Drug | alpha-ketoisocaproate | 1.77e-04 | 79 | 6 | 2 | CID000000070 | |
| Drug | 2-(N-morpholino)ethanesulfonic acid | 2.09e-04 | 86 | 6 | 2 | CID000078165 | |
| Drug | 2'-deoxy-3'-thiacytidine | 2.14e-04 | 87 | 6 | 2 | CID000003877 | |
| Drug | AC1L191M | 2.24e-04 | 89 | 6 | 2 | CID000000350 | |
| Drug | troglitazone | 2.33e-04 | 526 | 6 | 3 | CID000005591 | |
| Drug | AOAA | 2.35e-04 | 91 | 6 | 2 | CID000000285 | |
| Drug | pyridoxine | 2.56e-04 | 95 | 6 | 2 | CID000001054 | |
| Drug | p,p'-DDE | 2.66e-04 | 97 | 6 | 2 | CID000003035 | |
| Drug | trimethoprim | 2.78e-04 | 99 | 6 | 2 | CID000005578 | |
| Drug | pyridoxamine | 3.12e-04 | 105 | 6 | 2 | CID000001052 | |
| Drug | kynurenine | 3.30e-04 | 108 | 6 | 2 | CID000000846 | |
| Drug | G-F-P | 3.36e-04 | 109 | 6 | 2 | CID000449515 | |
| Drug | AC1L1A5Z | 3.49e-04 | 111 | 6 | 2 | CID000000850 | |
| Drug | azathioprine | 4.08e-04 | 120 | 6 | 2 | CID000002265 | |
| Drug | kynurenic acid | 4.21e-04 | 122 | 6 | 2 | CID000003845 | |
| Drug | NSC521040 | 4.28e-04 | 123 | 6 | 2 | CID000001041 | |
| Drug | luteolin | 4.85e-04 | 131 | 6 | 2 | CID005280445 | |
| Drug | pyridoxal | 5.15e-04 | 135 | 6 | 2 | CID000001050 | |
| Drug | 13-HODE | 5.23e-04 | 136 | 6 | 2 | CID000001424 | |
| Drug | l-Alanyl-l-glutamine | 6.36e-04 | 150 | 6 | 2 | CID000123935 | |
| Disease | Machado-Joseph disease (implicated_via_orthology) | 2.07e-07 | 4 | 6 | 2 | DOID:1440 (implicated_via_orthology) | |
| Disease | body fat percentage | 8.66e-05 | 488 | 6 | 3 | EFO_0007800 | |
| Disease | body surface area | 1.96e-04 | 643 | 6 | 3 | EFO_0022196 | |
| Disease | waist circumference | 3.04e-03 | 429 | 6 | 2 | EFO_0004342 | |
| Disease | red blood cell density measurement | 1.23e-02 | 880 | 6 | 2 | EFO_0007978 | |
| Disease | hematocrit | 1.60e-02 | 1011 | 6 | 2 | EFO_0004348 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FNQMKGFVQAVMGQF | 166 | Q13349 | |
| QMELQQIMKGNFSAF | 311 | O94808 | |
| LQQIMKGNFSSFMQK | 331 | Q06210 | |
| KQMGFANMSVVLQQF | 1371 | P08F94 | |
| QFKGQQGQKRFQDMM | 121 | P12956 | |
| MPSQAFLQFQGKKNM | 596 | Q6GYQ0 |